Huiying Gu1, Paul R Territo2, Scott A Persohn2, Amanda A Bedwell2, Kierra Eldridge2, Rachael Speedy2, Zhe Chen1, Wei Zheng3, Yansheng Du4. 1. Department of Neurology, Indiana University School of Medicine, Indianapolis, IN, 46202, United States. 2. Department of Radiology and Imaging Sciences, Indiana University School of Medicine, Indianapolis, IN, 46202, United States. 3. School of Health Sciences, Purdue University, West Lafayette, IN, 47907, United States. 4. Department of Neurology, Indiana University School of Medicine, Indianapolis, IN, 46202, United States. Electronic address: ydu@iupui.edu.
Abstract
BACKGROUND: Lead (Pb) is an environmental factor has been suspected of contributing to the dementia including Alzheimer's disease (AD). Our previous studies have shown that Pb exposure at the subtoxic dose increased brain levels of beta-amyloid (Aβ) and amyloid plaques, a pathological hallmark for AD, in amyloid precursor protein (APP) transgenic mice, and is hypothesized to inhibit Aβ clearance in the blood- cerebrospinal fluid (CSF) barrier. However, it remains unclear how different levels of Pb affect Aβ clearance in the whole blood-brain barrier system. This study was designed to investigate whether chronic exposure of Pb affected the permeability of the blood-brain barrier system by using the Dynamic Contrast-Enhanced Computerized Tomography (DCE-CT) method. METHODS: DEC-CT was used to investigate whether chronic exposure of toxic Pb affected the permeability of the real-time blood brain barrier system. RESULTS: Data showed that Pb exposure increased permeability surface area product, and also significantly induced brain perfusion. However, Pb exposure did not alter extracellular volumes or fractional blood volumes of mouse brain. CONCLUSION: Our data suggest that Pb exposure at subtoxic and toxic levels directly targets the brain vasculature and damages the blood brain barrier system.
BACKGROUND: Lead (Pb) is an environmental factor has been suspected of contributing to the dementia including Alzheimer's disease (AD). Our previous studies have shown that Pb exposure at the subtoxic dose increased brain levels of beta-amyloid (Aβ) and amyloid plaques, a pathological hallmark for AD, in amyloid precursor protein (APP) transgenic mice, and is hypothesized to inhibit Aβ clearance in the blood- cerebrospinal fluid (CSF) barrier. However, it remains unclear how different levels of Pb affect Aβ clearance in the whole blood-brain barrier system. This study was designed to investigate whether chronic exposure of Pb affected the permeability of the blood-brain barrier system by using the Dynamic Contrast-Enhanced Computerized Tomography (DCE-CT) method. METHODS: DEC-CT was used to investigate whether chronic exposure of toxic Pb affected the permeability of the real-time blood brain barrier system. RESULTS: Data showed that Pb exposure increased permeability surface area product, and also significantly induced brain perfusion. However, Pb exposure did not alter extracellular volumes or fractional blood volumes of mouse brain. CONCLUSION: Our data suggest that Pb exposure at subtoxic and toxic levels directly targets the brain vasculature and damages the blood brain barrier system.
Authors: J Miklossy; K Taddei; R Martins; G Escher; R Kraftsik; O Pillevuit; D Lepori; M Campiche Journal: J Neuropathol Exp Neurol Date: 1999-08 Impact factor: 3.685
Authors: E K Weidman; C P Foley; O Kallas; J P Dyke; A Gupta; A E Giambrone; J Ivanidze; H Baradaran; D J Ballon; P C Sanelli Journal: AJNR Am J Neuroradiol Date: 2016-03-10 Impact factor: 3.825
Authors: Michael J Thrippleton; Walter H Backes; Steven Sourbron; Michael Ingrisch; Matthias J P van Osch; Martin Dichgans; Franz Fazekas; Stefan Ropele; Richard Frayne; Robert J van Oostenbrugge; Eric E Smith; Joanna M Wardlaw Journal: Alzheimers Dement Date: 2019-04-25 Impact factor: 21.566
Authors: Irina Petrushina; Armine Hovakimyan; Indira S Harahap-Carrillo; Hayk Davtyan; Tatevik Antonyan; Gor Chailyan; Konstantin Kazarian; Maxim Antonenko; Amandine Jullienne; Mary M Hamer; Andre Obenaus; Olga King; Karen Zagorski; Mathew Blurton-Jones; David H Cribbs; Harry Lander; Anahit Ghochikyan; Michael G Agadjanyan Journal: Neurobiol Dis Date: 2020-02-28 Impact factor: 5.996
Authors: Qingfeng Wen; Marcha Verheijen; Mandy Melissa Jane Wittens; Julia Czuryło; Sebastiaan Engelborghs; Duncan Hauser; Marcel H M van Herwijnen; Thomas Lundh; Ingvar A Bergdahl; Soterios A Kyrtopoulos; Theo M de Kok; Hubert J M Smeets; Jacco Jan Briedé; Julian Krauskopf Journal: Sci Rep Date: 2022-09-24 Impact factor: 4.996